How ARKG’s Genomics Will Personalize Cancer Treatment
March 31, 2021 at 09:36 AM EDT
Patients may suffer from the same ailments, but no two medical problems are exactly alike. That much is confirmed by genetic code, indicating the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is an avenue for investors looking to tap into increasing levels of personalized care in cancer...